MRC1 and myeloid sarcoma: The distribution of pro- or anti-inflammatory markers in MS tissue reveals the predominance of myeloid cells with an intermediate activation status, as defined by the coexpression of CD40 (typical of pro-inflammatory APCs) and the mannose receptor (CD206, typical of anti-inflammatory macrophages) at active lesions [133].